Metabolic Stability and Pharmaceutical Companies

The Data-Driven Future of Drug Development

DrugBank

OCTOBER 17, 2024

By harnessing the vast amounts of data generated throughout the development pipeline, pharmaceutical companies can accelerate the discovery of novel therapies, optimize clinical trial design, enhance drug safety monitoring, and deliver personalized medicine, ultimately improving patient outcomes and transforming the future of healthcare.

Drug Development

Drug Development Metabolic Stability Clinical Trials Drugs

We Need Better Benchmarks for Machine Learning in Drug Discovery

Practical Cheminformatics

AUGUST 3, 2023

Initially, I would recommend aqueous solubility, membrane permeability, in vitro metabolic stability, and biochemical assays. Many have suggested that pharmaceutical companies should open more of their data to the community. I have a few ideas. The Biogen dataset is a good start, but we need more data.

Drugs

Drugs Biochemical Assays Metabolic Stability Screening Hits

Drug Discovery Digest

The Data-Driven Future of Drug Development

We Need Better Benchmarks for Machine Learning in Drug Discovery

Webinars

Stay Connected